Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2024-03-15
2024-08-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Total30 for Astigmatism Contact Lenses
NCT06052046
Comparison of Clinical Performance of Two Monthly Replacement Toric Soft Contact Lenses
NCT06165627
To Evaluate the Performance of Total 30 (Lehifilcon A) Contact Lenses in Patients Using Digital Devices for Greater Than 8 Hours Per Day 5 Days Per Week Based on Subjective Reported Data.
NCT06317038
Evaluation of Wear Experience With a Weekly Replacement Soft Contact Lens in Neophyte Lens Wearers With Astigmatism
NCT06751225
Post-market Clinical Follow-up Study of Alcon TOTAL30® Contact Lenses (Lehfilcon A)
NCT06408649
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Contact lens (CL) discomfort affects most CL wearers with discomfort consistently topping the reasons why established CL wearers drop out of CLs. In fact, studies have consistently found that the frequency of CL dropout is around 20% with this dropout frequency staying relatively stable over the past 20 plus years. This static frequency of CL dropout is surprising since there have been a number of dramatic soft CL innovations during this time frame (e.g., widely available daily disposable CLs, silicone hydrogel CL materials with high oxygen transmissibility, new CL surface coatings). CL discomfort and dropout could be affected by significant time spent on digital devices and DES. Maintaining ocular comfort with satisfactory CL performance (comfort, lack of dryness, and overall good vision) is key to overall success. This could be especially important in patients who wear astigmatic CLs, yet the community currently lacks data on this topic.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Total 30 for astigmatism contact lenses
Total30 for Astigmatism Monthly Replacement Contact Lenses
Total30 for Astigmatism Contact Lenses
Participants must be refit into Total30 for Astigmatism Contact Lenses and wear them over the course of this one month study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Total30 for Astigmatism Contact Lenses
Participants must be refit into Total30 for Astigmatism Contact Lenses and wear them over the course of this one month study.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 0.00 LogMAR visual acuity or better in their habitual CLs or by manifest refraction in both eyes
* Smart phone with text messaging capabilities
* Existing wearers of soft, frequent replacement toric CLs within past 6 months
* Frequent digital device user (e.g., phone, iPad, computer, social media, video streaming, etc.) defined as at least 8 hours of usage per day
* Willing to follow the required wear schedule
* Astigmatism ranging from 0.75 D to 2.50 D in each eye
* Willing to wear their CLs at least 13 hours/day
Exclusion Criteria
* Have a history of ocular surgery within the past 12 months
* Have a history of severe ocular trauma, active ocular infection or inflammation
* Have a history of viral eye disease
* Currently using isotretinoin-derivatives or ocular medications
* Currently using a dry eye treatment including but not limited to artificial tears
* Currently using rewetting drops daily or occasionally
* If they are pregnant or breast feeding
* Need for spectacle add power of any amount (presbyopic)
* Currently wearing T30fA CLs
* Have a history of wearing hard CLs
* Subjects who show excessive lens oscillation with the T30fA lenses during the fitting process yet show 0.0 logMAR acuity, will be excluded from the study.
* Patients who report unstable vision while wearing their habitual or study CLs (e.g., rotational instability of CLs)
* Willing to not use any artificial tears or dry eye treatments during the study
* Willing to not use rewetting drops during the study
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Southern College of Optometry
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kannar Eye Care
Pittsburg, Kansas, United States
Coldwater VIsion Center
Coldwater, Mississippi, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00006733
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.